Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$471.270.0%
Market Cap$127.3bn
VRTX overview
Crunching data... Almost there!
VRTX Intrinsic value
VRTX Intrinsic value overview
VRTX Historical intrinsic value
VRTX Financials
VRTX Income statement
Crunching data... Almost there!
VRTX Balance sheet
Crunching data... Almost there!
VRTX Cash flow statement
Crunching data... Almost there!
VRTX Financial ratios
VRTX Growth
Crunching data... Almost there!
VRTX Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more VRTX fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Vertex Pharmaceuticals Incorporated (VRTX) stock?
As of today, intrinsic value of Vertex Pharmaceuticals Incorporated is $277.9.
Is Vertex Pharmaceuticals Incorporated (VRTX) stock undervalued or overvalued?
As of today, Vertex Pharmaceuticals Incorporated is overvalued by 69.6%, compared to the current market share price of $471.27.
What is Vertex Pharmaceuticals Incorporated (VRTX) stock rating?
As of today, Vertex Pharmaceuticals Incorporated has a stock rating of 7 (out of 10), which is considered Great.
is Vertex Pharmaceuticals Incorporated (VRTX) a good stock to buy?
As of today, Vertex Pharmaceuticals Incorporated has a Great stock rating, which is 69.6% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.